Figure 2.
Definition and distribution of the UKALL prognostic index, along with association with risk of relapse. (A) The linear model derived from the coefficients of the multivariate model. (B-C) Bar charts show the distribution of the patient-specific prognostic index values derived from the model for the discovery (B) and validation (C) cohorts. The in-laid table gives the mean, median, standard deviation (SD), and minimum/maximum values of the distribution. The line shows the smoothed risk of relapse estimated for 10 equal-sized subgroups. (D) Table shows hazard ratios for the UKALL prognostic index as a continuous variable from univariate Cox models across the 2 cohorts and 3 trials within the validation cohort. CYTO-GR, cytogenetic good risk; CYTO-HR, cytogenetic HR; τ(WCC), log-transformed WCC value.

Definition and distribution of the UKALL prognostic index, along with association with risk of relapse. (A) The linear model derived from the coefficients of the multivariate model. (B-C) Bar charts show the distribution of the patient-specific prognostic index values derived from the model for the discovery (B) and validation (C) cohorts. The in-laid table gives the mean, median, standard deviation (SD), and minimum/maximum values of the distribution. The line shows the smoothed risk of relapse estimated for 10 equal-sized subgroups. (D) Table shows hazard ratios for the UKALL prognostic index as a continuous variable from univariate Cox models across the 2 cohorts and 3 trials within the validation cohort. CYTO-GR, cytogenetic good risk; CYTO-HR, cytogenetic HR; τ(WCC), log-transformed WCC value.

Close Modal

or Create an Account

Close Modal
Close Modal